Logfresh Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 12.59%
- Profit Growth -62.58%
- Ebitda 23.12%
- Net Worth 0.12%
- Total Assets 14.23%
About Logfresh Biotechnology
Logfresh Biotechnology Private Limited (LBPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 July 2019 (Five years and six months 5 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Selarka and Venugopal Agarwal serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299MH2019PTC328705
-
Company No.
328705
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Jul 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Logfresh Biotechnology?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Selarka
|
Director | 31-Jul-2019 | Current |
|
Venugopal Agarwal
|
Director | 31-Jul-2019 | Current |
Financial Performance of Logfresh Biotechnology.
Logfresh Biotechnology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.59% increase. The company also saw a substantial fall in profitability, with a 62.58% decrease in profit. The company's net worth moved up by a moderate rise of 0.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Logfresh Biotechnology?
In 2023, Logfresh Biotechnology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Balaji Buildcraft Infra Private LimitedVenugopal Agarwal is a mutual person
-
Shri Chaturbhuj Agarwal Charitable Foundation
Venugopal Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Logfresh Biotechnology?
Unlock and access historical data on people associated with Logfresh Biotechnology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Logfresh Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Logfresh Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.